| |
| |
| |
| Introduction | |
| |
| |
| |
| Basic Principles and Pharmacodynamics | |
| |
| |
| |
| Pharmacokinetics | |
| |
| |
| |
| Autonomic Pharmacology | |
| |
| |
| |
| Drug Interactions | |
| |
| |
| |
| Impact of Age on Pharmacology | |
| |
| |
| |
| Pharmacogenetics | |
| |
| |
| |
| Toxicology | |
| |
| |
| |
| Herbal Medications | |
| |
| |
| |
| Drug Discovery and Evaluation | |
| |
| |
| |
| Addiction and Abuse | |
| |
| |
| |
| Drug Classes | |
| |
| |
| |
| Cardiology | |
| |
| |
| ACEi | |
| |
| |
| ARB | |
| |
| |
| Direct renin | |
| |
| |
| Na channels | |
| |
| |
| Beta blockers | |
| |
| |
| K blockers | |
| |
| |
| CCB | |
| |
| |
| Anticholinergics | |
| |
| |
| Adenosine | |
| |
| |
| Digoxin | |
| |
| |
| Statins | |
| |
| |
| Fibrates | |
| |
| |
| Bile acid sequestrants | |
| |
| |
| Pressors | |
| |
| |
| PDE3 | |
| |
| |
| Nitrates | |
| |
| |
| Vasodilators | |
| |
| |
| Natriuretic peptides | |
| |
| |
| |
| Cough, Cold, and Allergy | |
| |
| |
| Antitussives | |
| |
| |
| Expectorants | |
| |
| |
| Decongestants | |
| |
| |
| H1 antagonists | |
| |
| |
| Mast cell stabilizers | |
| |
| |
| |
| Dermatology | |
| |
| |
| Retinoids | |
| |
| |
| Steroids-topical | |
| |
| |
| Keratolytics | |
| |
| |
| Imiquimod | |
| |
| |
| |
| Endocrinology | |
| |
| |
| Alpha-glucosidase inhibitors | |
| |
| |
| Biguanides | |
| |
| |
| Incretins | |
| |
| |
| Insulins | |
| |
| |
| Meglitinides | |
| |
| |
| Sulfonylureas | |
| |
| |
| Thiazolidinediones | |
| |
| |
| Glucagon | |
| |
| |
| Estrogens | |
| |
| |
| Estrogen receptor antagonists | |
| |
| |
| Aromatase inhibitors | |
| |
| |
| Progestins | |
| |
| |
| Hormone contraception | |
| |
| |
| Oxytocin | |
| |
| |
| Prostaglandins-Reproduction | |
| |
| |
| Androgen antagonists | |
| |
| |
| Androgens | |
| |
| |
| Somatostatin Analogs | |
| |
| |
| GH antagonists | |
| |
| |
| ACTH | |
| |
| |
| Thyroid replacement | |
| |
| |
| Anti-thyroid | |
| |
| |
| |
| Gastroenterology | |
| |
| |
| Antacids-buffers | |
| |
| |
| H2 antagonists | |
| |
| |
| Proton pump inhibitors | |
| |
| |
| GI cytoprotectants | |
| |
| |
| Prokinetics: Dopamine antagonists | |
| |
| |
| Antidiarrheals | |
| |
| |
| Laxatives | |
| |
| |
| Cannabinoids | |
| |
| |
| Pancreatic enzymes | |
| |
| |
| Serotonin antagonists | |
| |
| |
| |
| Hematology | |
| |
| |
| Heparins | |
| |
| |
| Direct Xa inhibitors | |
| |
| |
| Direct thrombin inhibitors | |
| |
| |
| Coumarins | |
| |
| |
| Salicylates | |
| |
| |
| ADP blockers | |
| |
| |
| Anti-platelet IIb/IIIa inhibitors | |
| |
| |
| Fibrinolytics | |
| |
| |
| Erythropoietins | |
| |
| |
| Colony stimulating factors | |
| |
| |
| B vitamins | |
| |
| |
| Iron | |
| |
| |
| |
| Immune Modifiers | |
| |
| |
| Steroids-Systemic | |
| |
| |
| INTRO Monoclonal Antibodies | |
| |
| |
| B Cell Biologics | |
| |
| |
| T Cell Biologics | |
| |
| |
| Mixed Biologics | |
| |
| |
| TNF Inhibitors | |
| |
| |
| Antimetabolites | |
| |
| |
| Calcineurin inhibitors | |
| |
| |
| Targets of Rapamycin (TOR) | |
| |
| |
| Activated Protein C | |
| |
| |
| Glatiramer | |
| |
| |
| |
| Infectious Diseases | |
| |
| |
| INTRO antibiotics | |
| |
| |
| Penicillins | |
| |
| |
| Cephalosporins | |
| |
| |
| Carbapenems | |
| |
| |
| Glycopeptides | |
| |
| |
| Fluoroquinolones | |
| |
| |
| Aminoglycosides | |
| |
| |
| Lincosamides | |
| |
| |
| Tetracyclines | |
| |
| |
| Macrolides | |
| |
| |
| Oxazolidinones | |
| |
| |
| Sulphonamides | |
| |
| |
| Metronidazole | |
| |
| |
| INTRO anti-mycobacterials | |
| |
| |
| Ethambutol | |
| |
| |
| Isoniazid | |
| |
| |
| Pyrazinamide | |
| |
| |
| Rifamycins | |
| |
| |
| CCR5 antagonists | |
| |
| |
| Fusion inhibitors | |
| |
| |
| Integrase inhibitors | |
| |
| |
| Nucleoside reverse transcriptase inhibitors (NRTI) | |
| |
| |
| Non-Nucleoside reverse transcriptase inhibitors (nNRTI) | |
| |
| |
| Protease inhibitors | |
| |
| |
| Uncoating inhibitors | |
| |
| |
| Neuraminidase inhibitors | |
| |
| |
| Nucleoside analogs | |
| |
| |
| Azole antifungals | |
| |
| |
| Echinocandins | |
| |
| |
| Griseofulvin | |
| |
| |
| Polyenes | |
| |
| |
| Pyrimidine analogs | |
| |
| |
| Terbinafine | |
| |
| |
| Aminoquinolines | |
| |
| |
| Anti-helminthics | |
| |
| |
| Anti-protozoals | |
| |
| |
| |
| Musculoskeletal System | |
| |
| |
| Bisphosphonates | |
| |
| |
| Calcitriol | |
| |
| |
| Parathyroid hormone | |
| |
| |
| RANKL inhibitors | |
| |
| |
| Colchicine | |
| |
| |
| NSAIDs | |
| |
| |
| Uricosurics | |
| |
| |
| Xanthine oxidase inhibitors | |
| |
| |
| |
| Neoplasia | |
| |
| |
| Alkylators | |
| |
| |
| Anthracyclines | |
| |
| |
| Antimetabolites | |
| |
| |
| Bleomycins | |
| |
| |
| Platinum compounds | |
| |
| |
| Taxanes | |
| |
| |
| Topoisomerase inhibitors | |
| |
| |
| Vinca alkaloids | |
| |
| |
| GnRH analogues | |
| |
| |
| Angiogenesis inhibitors | |
| |
| |
| Tyrosine kinase inhibitors | |
| |
| |
| |
| Neurology and Neuromuscular | |
| |
| |
| Acetaminophen | |
| |
| |
| Opioids | |
| |
| |
| Alpha 2 Agonists | |
| |
| |
| Anesthetics-Inhaled | |
| |
| |
| Anesthetics-Intravenous | |
| |
| |
| Anesthetics-Local | |
| |
| |
| Baclofen | |
| |
| |
| Depolarizing neuromuscular blockers | |
| |
| |
| Non-depolarizing neuromuscular blockers | |
| |
| |
| Nicotine | |
| |
| |
| Dopamine and dopamine agonists | |
| |
| |
| COMT inhibitors | |
| |
| |
| Cholinesterase inhibitors | |
| |
| |
| Ergot alkaloids | |
| |
| |
| Triptans | |
| |
| |
| Topiramate | |
| |
| |
| Phenytoin | |
| |
| |
| Lamotrigine | |
| |
| |
| GABA analogues | |
| |
| |
| Carbamazepine | |
| |
| |
| Barbiturates | |
| |
| |
| Valproate | |
| |
| |
| |
| Ophthalmology | |
| |
| |
| Prostaglandins, Ophthalmic | |
| |
| |
| Aptamers | |
| |
| |
| |
| Psychiatry | |
| |
| |
| Serotonin selective reuptake inhibitors (SSRI) | |
| |
| |
| Tricyclic Antidepressants (TCAs) | |
| |
| |
| Serotonin Noradrenaline reuptake inhibitors (SNRIs) | |
| |
| |
| Noradrenergic and specific serotonergic antidepressants (NaSSAs) | |
| |
| |
| Monoamine Oxidase Inhibitors (MAOIs) | |
| |
| |
| Noradrenaline and Dopamine reuptake inhibitors (NDRI) | |
| |
| |
| Lithium | |
| |
| |
| First generation antipsychotics | |
| |
| |
| Second generation antipsychotics | |
| |
| |
| Benzodiazepines | |
| |
| |
| CNS stimulants | |
| |
| |
| |
| Pulmonary | |
| |
| |
| Beta-2 Agonists (Bronchodilators) | |
| |
| |
| Anti-Cholinergics, Inhaled | |
| |
| |
| Leukotriene Receptor Antagonists (LTRA) | |
| |
| |
| Methylxanthines | |
| |
| |
| Inhaled Corticosteroids | |
| |
| |
| Phosphodiesterase 5 Inhibitors | |
| |
| |
| Endothelin receptor antagonists | |
| |
| |
| Prostaglandins, Vascular | |
| |
| |
| |
| Renal/Genitourinary | |
| |
| |
| Thiazide Diuretics | |
| |
| |
| Loop Diuretics | |
| |
| |
| Potassium-sparing Diuretics | |
| |
| |
| Carbonic Anhydrase Inhibitors | |
| |
| |
| Osmotic Diuretics | |
| |
| |
| Antidiuretic Hormone (Vasopressin) Analogues | |
| |
| |
| Anticholinergics- Bladder | |
| |
| |
| Alpha 1 Antagonists | |
| |
| |
| 5-alpha reductase inhibitors | |